Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Li XL et al. – The data suggest that direct priming by TAP1 and B7.1 co–expressing tumour cells is potentially a major mechanism to facilitate immune responses against TAP–deficient tumour cells.

Related Articles

The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours
Clinical and Experimental Immunology, 10/06/09    Relevance Score: 66%

The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer
Acta Oncologica, 11/02/09    Relevance Score: 48%

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial
European Journal of Cancer, 10/13/09    Relevance Score: 46%

Cutaneous metastasis from gastric glomus tumour
Clinical and Experimental Dermatology, 10/05/09    Relevance Score: 46%

Juxtarenal/pararenal Wilms’ tumour in a six-year-old Malay girl
Singapore Medical Journal, 10/05/09    Relevance Score: 46%

Today in Allergy/Immunology...keeping you current

Occupational Allergy in Strawberry Greenhouse Workers
International Archives of Allergy and Immunology, 11/30/09

Xolair Is Effective in Allergics with a Low Serum IgE Level
International Archives of Allergy and Immunology, 11/30/09

Efficient serum clearance of botulinum neurotoxin using a pool of small antitoxin binding agents
Infection and Immunity, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address